✦ LIBER ✦

Clinical end points for the assessment of cytostatic agents

✍ Scribed by Rinaldi, M

Book ID: 118570928
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 46 KB
Volume: 38
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(02)00251-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

`The surrogacy of virologic end points f

`The surrogacy of virologic end points for clinical end points has not been fully validated'

✍ Bankhead, Charles 📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

Selection of Reproductive Health End Poi

Selection of Reproductive Health End Points for Environmental Risk Assessment

✍ David A. Savitz and Sioban D. Harlow 📂 Article 📅 1991 🏛 Environmental Health Information Service 🌐 English ⚖ 435 KB

Novel Targeted Agents and the Need to Re

Novel Targeted Agents and the Need to Refine Clinical End Points in Chronic Lymphocytic Leukemia

✍ Cheson, B. D.; Byrd, J. C.; Rai, K. R.; Kay, N. E.; O'Brien, S. M.; Flinn, I. W. 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 66 KB

Progression-free survival as an end-poin

Progression-free survival as an end-point in clinical trials of biotherapeutic agents

✍ Lothar Bergmann; Steven Hirschfeld; Charles Morris; Sergio Palmeri; Andrew Stone 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Assessment of an end-point microassay fo

Assessment of an end-point microassay for varicella vaccine

✍ Jocelyne Husson-van Vliet 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 139 KB

A Concise Display of Multiple End Points

A Concise Display of Multiple End Points for Benefit–Risk Assessment

✍ Levitan, B 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 158 KB